Metropolitan Life Insurance Company (MetLife)’s inTEST INTT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio INTT Stock Details INTT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-590	Closed	-$7.82K	–	1043
2024 Q1	$7.82K	Hold	590	–	–	﹤0.01%	2204
2023 Q4	$8.02K	Hold	590	–	–	﹤0.01%	2241
2023 Q3	$8.95K	Hold	590	–	–	﹤0.01%	2258
2023 Q2	$15.5K	Buy	+590	New	+$13K	﹤0.01%	2068

Other funds holding INTT

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s INTT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of inTEST (INTT) in Q2 2024, closing a stake of 590 shares — an estimated $7.82K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INTT in Q2 2023 and held it in 4 quarters. The position peaked at $15.5K in Q2 2023. 75 funds tracked by Wall St. Rank hold INTT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining inTEST position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 590 inTEST shares in Q2 2024, an estimated $7.82K.
Metropolitan Life Insurance Company (MetLife) first reported a position in inTEST in Q2 2023 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s inTEST position peaked at $15.5K in Q2 2023.
75 funds tracked by Wall St. Rank held inTEST as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.